Author(s):
Amol V. More, Ritesh B. Aher, Vimal Patel, Bhavesh Akbari
Email(s):
riteshswami2025@gmail.com
DOI:
10.52711/2231-5675.2026.00032 
Address:
Amol V. More1*, Ritesh B. Aher1*, Vimal Patel2, Bhavesh Akbari3
1Research Scholar, School of Pharmacy, P.P. Savani University, Dhamdod, Surat, Gujrat, India.
2Associate Professor, School of Pharmacy, P.P. Savani University, Dhamdod, Surat, Gujrat, India.
3Principal and Professor, School of Pharmacy, P.P. Savani University, Dhamdod, Surat, Gujrat, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2026
ABSTRACT:
Hypertension is a major health challenge in the world that requires the use of antihypertensive drugs over a period of time. Quality, safety and effectiveness of such medications largely depend on the reliable analytical methods. Analytical methods are important in pharmaceutical analysis in the quantitative and qualitative assessment of antihypertensive compounds in bulk substances, drug formulations, and biological samples. This review is a detailed discussion of the principles, plans, and regulatory aspects that pertain to the creation and certification of the analytical approaches of antihypertensive drugs. Some of the more frequently used methods of analysis include UV-Visible spectrophotometry, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Liquid Chromatography Mass Spectrometry and stability-indicating methods. It is centered on the parameters of optimization of methods, the criteria of validation used in accordance with ICH guidelines, new trends, and obstacles to quality control of pharmaceutical products.
Cite this article:
Amol V. More, Ritesh B. Aher, Vimal Patel, Bhavesh Akbari. Analytical Method Development and Validation of Antihypertensive Drugs: A Comprehensive Review. Asian Journal of Pharmaceutical Analysis. 2026; 16(3):210-8. doi: 10.52711/2231-5675.2026.00032
Cite(Electronic):
Amol V. More, Ritesh B. Aher, Vimal Patel, Bhavesh Akbari. Analytical Method Development and Validation of Antihypertensive Drugs: A Comprehensive Review. Asian Journal of Pharmaceutical Analysis. 2026; 16(3):210-8. doi: 10.52711/2231-5675.2026.00032 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2026-16-3-8
9. REFERENCES:
1. Alshora, D. H., Sherif, A. Y., and Ibrahim, M. A. Development and validation of a UPLC method for simultaneous estimation of antihypertensive drugs in fixed-dose combinations. Processes. 2024; 12(6): 1259. https://doi.org/10.3390/pr12061259
2. Attia, K. A. M., Abdel-Monem, A. H., Abdel-Raoof, A. M., and El-Sayed, H. M. Highly sensitive HPLC method for cardiovascular drugs using dual detection. Scientific Reports. 2025; 15: 12229. https://doi.org/10.1038/s41598-025-94907-0
3. Blessy, M., Patel, R. D., Prajapati, P. N., and Agrawal, Y. K. Development of forced degradation and stability-indicating studies of drugs—A review. Journal of Pharmaceutical Analysis. 2014;4(3): 159–165. https://doi.org/10.1016/j.jpha.2013.09.003
4. El Karbane, M., and Benchekroun, Y. H. UPLC-DAD method for simultaneous determination of antihypertensive drugs. Journal of AOAC International. 2021; 104(3): 562–570.
5. Gorog, S. The importance of impurity profiling of pharmaceutical products. TrAC Trends in Analytical Chemistry. 2018;101: 2–10.
6. ICH Harmonised Guideline. Validation of analytical procedures: Text and methodology Q2 (R1). International Council for Harmonisation. 2005.
7. ICH Harmonised Guideline. Q14: Analytical procedure development (Draft). International Council for Harmonisation. 2019.
8. International Conference on Harmonisation. ICH Q2 (R1) validation of analytical procedures. ICH Secretariat. 2005.
9. Kazakevich, Y., and Lobrutto, R. HPLC for pharmaceutical scientists. Wiley-Interscience. 2007.
10. Khuroo, A. H., and Monif, T. Regulatory perspectives on analytical method validation. Journal of Pharmaceutical Sciences. 2020; 109(1): 35–42.
11. Kumar, N., and Singh, R. Analytical techniques for antihypertensive drugs: A review. Asian Journal of Pharmaceutical Sciences. 2019; 14(6): 609–623.
12. Li, K., Wen, Y., and Chen, J. Application of LC–MS/MS in pharmaceutical analysis. Journal of Chromatography B. 2021; 1178: 122809.
13. McPolin, O. An introduction to HPLC for pharmaceutical analysis. Mourne Training Services. 2009
14. Meyer, V. R. Practical high-performance liquid chromatography (4th ed.). Wiley. 2010
15. Patel, B. N., Sharma, N., Sanyal, M., and Shrivastav, P. S. Stability-indicating methods in pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis. 2018; 147: 39–58.
16. Ranganath, M. K., Sudha, P. D. C., Ramesh, G., and Dang, R. HPLC method development and validation of antihypertensive drugs. Indian Journal of Pharmaceutical Education and Research. 2024; 58(3): 1053–1061.
17. Rashid, M. A., Shazly, G., and Kazi, M. UHPLC-UV method for valsartan and nifedipine. Separations. 2022; 9(11) : 325.
18. Snyder, L. R., Kirkland, J. J., and Dolan, J. W. Introduction to modern liquid chromatography (3rd ed.). Wiley. 2010.
19. Skoog, D. A., Holler, F. J., and Crouch, S. R. Principles of instrumental analysis (6th ed.). Cengage Learning. 2014.
20. Swartz, M. E., and Krull, I. S. Analytical method development and validation. CRC Press. 2018.
21. United States Food and Drug Administration. Analytical procedures and methods validation for drugs and biologics. FDA. 2015.
22. World Health Organization. WHO guidelines on pharmaceutical quality control. WHO Press. 2018.
23. Sebaiy, M. M., El-Adl, S. M., and Baraka, M. M. QbD-based RP-HPLC method for antihypertensive drugs. BMC Chemistry. 2022; 16: 70.
24. Tang, D., and Row, K. H. Green analytical chemistry in pharmaceutical analysis. Journal of Separation Science. 2019; 42(1): 1–14.
25. Tong, C., and Xu, X. Application of chemometrics in analytical method optimization. Analytical Methods. 2020; 12: 4210–4222.
26. Venkataraman, S., and Haritha, G. Chromatographic separation of antihypertensive drugs. Asian Journal of Pharmaceutical and Clinical Research. 2018; 11(9): 112–118.
27. Yadav, M., and Rao, R. N. Impurity profiling of pharmaceutical products. Journal of Pharmaceutical Analysis. 2019; 9(1): 1–15.
28. Yelmame, S. S., and Amrutkar, S. V. Validation of RP-HPLC dissolution method as per ICH. European Journal of Life Sciences. 2024; 3: 93–100.
29. Zhou, X., and Chen, Y. Advances in bioanalytical LC–MS/MS methods. Bioanalysis. 2021; 13(4): 267–281.
30. Kothapalli, L., and Subramanian, G. Stability studies in pharmaceutical analysis. Journal of Pharmaceutical Sciences. 2017; 106(9): 2284–2294.
31. Ahuja, S., and Rasmussen, H. HPLC method development for pharmaceuticals. Elsevier. 2007.
32. Ermer, J., and Miller, J. H. M. Method validation in pharmaceutical analysis. Wiley-VCH. 2005
33. Nagy, K., and Szepesi, G. Regulatory aspects of analytical method validation. Journal of Chromatography A. 2016; 1458: 1–9.
34. Rao, P. V., and Murthy, T. E. G. K. UV spectrophotometric analysis of antihypertensive drugs. International Journal of Pharmaceutical Sciences Review and Research. 2018: 51(2): 45–52.
35. Blessy, M., and Agrawal, Y. K. Analytical challenges in combination drug products. Journal of Pharmaceutical Analysis. 2015; 5(4): 211–223.
36. Zhang, H., and Wang, Y. Automation in pharmaceutical analytical laboratories. TrAC Trends in Analytical Chemistry. 2022; 150: 116579.
37. Shaikh, K. A., and Patil, A. T. Development of stability-indicating HPLC methods. Journal of Pharmaceutical Research International. 2020; 32(12): 21–31.
38. Iqbal, M., and Hussain, T. Analytical challenges in fixed-dose combination drugs. Future Journal of Pharmaceutical Sciences. 2021; 7: 156.
39. Rao, R. N., and Nagaraju, V. An overview of stability-indicating HPLC methods. Journal of Pharmaceutical and Biomedical Analysis. 2003; 33(3): 335–377.
40. World Health Organization. Guidelines on stability testing of pharmaceutical products. WHO. 2021.
41. Blessy, M., Patel, R. D., Prajapati, P. N., and Agrawal, Y. K. Development of forced degradation and stability indicating studies of drugs—A review. Journal of Pharmaceutical Analysis. 2014; 4(3): 159–165.
42. ICH Q1A(R2). Stability testing of new drug substances and products. International Council for Harmonisation, Geneva. 2003.
43. ICH Q2(R1). Validation of analytical procedures: Text and methodology. International Council for Harmonisation, Geneva. 2005.
44. ICH Q8(R2). Pharmaceutical development. International Council for Harmonisation, Geneva. 2009.
45. ICH Q9. Quality risk management. International Council for Harmonisation, Geneva. 2005.
46. ICH Q10. Pharmaceutical quality system. International Council for Harmonisation, Geneva. 2008.
47. Snyder, L. R., Kirkland, J. J., and Dolan, J. W. Introduction to Modern Liquid Chromatography (3rd ed.). Wiley. 2010.
48. Swartz, M. E., and Krull, I. S. Analytical Method Development and Validation. CRC Press. 2012.
49. Kazakevich, Y., and LoBrutto, R. HPLC for Pharmaceutical Scientists. Wiley. 2007.
50. Dong, M. W. Modern HPLC for Practicing Scientists. Wiley. 2016.
51. Bakshi, M., and Singh, S. Development of validated stability-indicating assay methods—critical review. Journal of Pharmaceutical and Biomedical Analysis. 2002; 28: 1011–1040.
52. Ermer, J., and Miller, J. H. Method Validation in Pharmaceutical Analysis. Wiley-VCH. 2005.
53. Ravisankar, P., et al. A review on analytical method development. Indian Journal of Research in Pharmacy and Biotechnology. 2015; 3(2): 130–142.
54. Skoog, D. A., Holler, F. J., and Crouch, S. R. Principles of Instrumental Analysis (6th ed.). Cengage Learning. 2018.
55. Willard, H. H., Merritt, L. L., Dean, J. A., and Settle, F. A. (Instrumental Methods of Analysis. CBS Publishers. 2004.
56. Ahuja, S., and Dong, M. W. Handbook of Pharmaceutical Analysis by HPLC. Elsevier. 2005.
57. Carstensen, J. T., and Rhodes, C. T. Drug Stability: Principles and Practices. Marcel Dekker. 2000.
58. Baertschi, S. W., et al.). Pharmaceutical Stress Testing. Informa Healthcare. 2011.
59. Chatwal, G. R., and Anand, S. K. Instrumental Methods of Chemical Analysis. Himalaya Publishing House. 2014.
60. Jeffery, G. H., et al. Vogel’s Textbook of Quantitative Chemical Analysis (5th ed.). Longman. 1989.
61. Miller, J. N., and Miller, J. C. Statistics and Chemometrics for Analytical Chemistry. Pearson. 2010.
62. Bolton, S., and Bon, CPharmaceutical Statistics: Practical and Clinical Applications. CRC Press. . 2010.
63. Taverniers, I., et al. Trends in quality in the analytical laboratory. TrAC Trends in Analytical Chemistry. 2004; 23(8): 535–552.
64. Rozet, E., et al. Analytical method validation and total error concept. Journal of Pharmaceutical and Biomedical Analysis. 2011; 55: 848–858.
65. Singh, S., and Bakshi, M. Guidance on conduct of stress tests. Pharmaceutical Technology. 2000; 24(2): 1–14.
66. Rao, R. N., and Nagaraju, V. Stability indicating HPLC methods—review. Journal of Pharmaceutical and Biomedical Analysis. 2003; 33: 335–377.